A double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson's disease

J. Kulisevsky, M. Barbanoj, A. Gironell, R. Antonijoan, M. Casas, B. Pascual-Sedano

Research output: Contribution to journalArticleResearch

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)25-31
JournalClin Neuropharmacol
Volume25
Issue number1
DOIs
Publication statusPublished - 1 Jan 2002

Cite this